Axsome Therapeutics - Nilai pasar AXSM

The price evolution of Axsome Therapeutics (AXSM) reflects the dynamics of a business focused on the expansion of innovative migraine and depression treatments in the US. The current figure is 8.16. Revenue stability is increasing due to steady demand for neurotherapy; however, high marketing costs, challenges in implementing new formulas, and pressure from insurance intermediaries threaten margins.

AXSM Axsome Therapeutics, Inc.: Biji pasar ing interval 04.07.2022 - 22.10.2026

AXSM (Axsome Corp): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Axsome Therapeutics (AXSM):

Kutipan saham Axsome Therapeutics, Inc.|AXSM - Prakiraan gabungan firma investasi|Nilai pasar Axsome Corp

Analisis fundamental perusahaan:AXSM (Axsome Therapeutics, Inc.)

Sampel barang axsome.com

Market capitalization measures the aggregate value of all the issuer's shares, reflecting the fundamental maturity of the business through the lens of market expectations. Analyzing the market's total valuation of Axsome Therapeutics (AXSM) allows for a correlation between the value of its assets and its strategy of repurposing known molecules, where the stability of this indicator confirms the effectiveness of bringing depression and migraine treatments to market.

Pesaing wigati

Biogen - Biji pasar|NBIX: Kapitalisasi pasar|RGC - Nilai pasar|Kapitalisasi pasar ACADIA Corp ACAD|Xenon Pharmaceuticals (XENE) - Nilai pasar|Biji pasar vikingtherapeutics.com|Nilai pasar Supernus|Kapitalisasi pasar CPRX (Catalyst Pharma)|Kapitalisasi pasar DNLI|HRMY - Nilai pasar|Biohaven Ltd. - Biji pasar|Kapitalisasi pasar amylyx.com AMLX|TRVI - Nilai pasar|Nilai pasar PRAX (Praxis Precision Medicines Inc)|Anavex Corp (AVXL) - Nilai pasar|Nilai pasar CeriBell EEG (CBLL)|PRTA (Prothena Corporation PLC) - Kapitalisasi pasar|Kapitalisasi pasar Alector Therapeutics|Biji pasar ANNX (Annexon)|omeros.com - Kapitalisasi pasar|Nilai pasar Neurogene Corp NGNE|Kapitalisasi pasar AC Immune Inc (ACIU)|VYGR - Nilai pasar|Nilai pasar neumoratx.com|Scilex (SCLX) - Nilai pasar|Biji pasar Tevogen Bio Holdings Inc.|ACOG (Alpha Cognition Inc) - Kapitalisasi pasar|Nilai pasar cogrx.com CGTX|Biji pasar IKT (Inhibikase Therapeutics)|SAVA (cassavasciences.com) - Nilai pasar|Assertio - Biji pasar|Nilai pasar COYA (Coya Therapeutics Inc)|VistaGen Therapeutics Inc - Kapitalisasi pasar|Nilai pasar OVID (Ovid Therapeutics Inc.)|ABOS: Kapitalisasi pasar|Nilai pasar cervomed.com (CRVO)|Nilai pasar Alterity Therapeutics Ltd.|CLNN: Nilai pasar|Kapitalisasi pasar PEPG|Kapitalisasi pasar jupiterneurosciences.com (JUNS)|Nilai pasar Relmada Therapeutics RLMD|ANVS (annovisbio.com) - Biji pasar|Grace Tx - Kapitalisasi pasar|Nilai pasar Firefly Neuroscience, Inc.|KLTO (anewmeds.com) - Biji pasar|NeuroSense Therapeutics Ltd. (NRSN) - Kapitalisasi pasar|Biji pasar RVPH|MTVA (MetaVia, Inc.) - Nilai pasar|Kapitalisasi pasar NRXS|Kapitalisasi pasar heliusmedical.com|Kapitalisasi pasar PASG (Passage Bio)|NEUP - Biji pasar|NERV - Nilai pasar|Kapitalisasi pasar athira.com ATHA|ADXN: Kapitalisasi pasar|Alzamend Neuro (ALZN) - Kapitalisasi pasar|Biji pasar CYCN|Kapitalisasi pasar PTIX (Protagenic)|Nilai pasar Pasithea Therapeutics (KTTA)|Kapitalisasi pasar cortigent.com|Nilai pasar Avenue Therapeutics, Inc. ATXI|BCLI - Biji pasar|CARA - Nilai pasar|CHRO (Chromocell) - Kapitalisasi pasar|ELYM: Kapitalisasi pasar|Nilai pasar Intra-Cellular Therapies, Inc. (ITCI)|Biji pasar LBPH|Kapitalisasi pasar Marinus Pharmaceuticals Inc|Nilai pasar NKGen (NKGN)|NRBO (NeuroBo Pharma) - Nilai pasar|Nilai pasar Sage Therapeutics, Inc. SAGE|synaptogen.com (SNPX) - Nilai pasar|Trevena - Kapitalisasi pasar|VIGL - Kapitalisasi pasar|WENA (Anew Medical, Inc.) - Biji pasar|Kapitalisasi pasar CERE